The first pill to treat postpartum depression was approved by the FDA Aug. 4, offering a new treatment option for about 500,000 women who develop the condition annually.

Twelve solutions made at Pfizer's Rocky Mount, N.C., facility — which a tornado struck in July — must now be ordered directly from the drugmaker's emergency ordering system, according to an Aug. 3 letter sent to customers. 

Eight drugs were recently added to the hundreds-long, growing list of medications in short supply, according to the FDA and the American Society of Health-System Pharmacists.

A CDC advisory committee has unanimously recommended AstraZeneca and Sanofi's jointly developed RSV immunization for infants who are younger than 8 months, according to an Aug. 3 press release. 

Mark Cuban Cost Plus Drug Co. has teamed up with numerous companies, including pharmacy benefit managers and independent pharmacies. 

GSK filed a lawsuit against Pfizer on Aug. 2, claiming Pfizer's respiratory syncytial virus vaccine infringes on patents related to its own RSV shot.

The Brooklyn Hospital, based in New York City, is teaming up with Clearway Health to gain access to medications that regional hospitals can have difficulty obtaining.

Central Admixture Pharmacy Services, a nationwide compounding pharmacy business that sells to hospitals and outpatient facilities, voluntarily recalled more than 13,000 bags of cardioplegia because of sterility concerns. 

The FDA and Drug Enforcement Administration are calling on stakeholders throughout the pharmaceutical supply chain to do all they can to boost available quantities of stimulant medications for the treatment of ADHD, binge-eating and narcolepsy, according to an Aug. 1 joint statement.

Months after the FDA reported multiple violations at an Intas Pharmaceuticals plant in India and blocked imports, the agency shared more details Aug. 1, including a report of an analyst pouring acid in a trash can filled with drug quality documents. 

The pharmacy team at New Orleans-based Ochsner Health is "pretty much begging" drug companies for critical drugs that are in short supply, according to Ryan Pepper, assistant vice president of pharmacy supply chain. 

Pharmaceutical giant Pfizer is laying off 69 employees in Lake Forest, Illinois, according to WARN filings published July 25.

Renton, Wash.-based Providence's pharmacy business, Credenda Health, opened its 22nd pharmacy in Portland, Ore. 

The National Institutes of Health announced plans to test at least four different treatments for long COVID, including Pfizer’s Paxlovid, as potential therapies for the lasting condition, according to a July 31 news release. 

Biogen has agreed to pay $7.3 billion to acquire Reata Pharmaceuticals — the maker of a new treatment for a rare genetic disorder. The deal is expected to close by the end of the year. 

Of the 13 Pfizer essential drugs the United States Pharmacopeia named as the most likely to go into new or worsened shortages, all of them are already in short supply. 

More than two dozen physicians, public health researchers and health policy experts are urging the federal government to publicly share registry data on the safety and efficacy of the Alzheimer's drug Leqembi. 

UofL Health's Mary & Elizabeth Hospital in Louisville, Ky., has opened its own full-service pharmacy, according to a July 27 news release. 

A phase 3 trial of an oral drug called zuranolone significantly improved symptoms of postpartum depression in just 15 days.

Indiana University Health, based in Indianapolis, recently unveiled its $40 million, 70,000-square-foot shared services pharmacy facility, according to a news release shared with Becker's.